Rättskällor med officiella primärkällor

Utskrivet ·

Skip to main content
Skip to the answer
ExploreWorldAIExploreWorldAI

Back to the decisions

Court of Justice of the European Union · Judgment

C-668/17 PViridis Pharmaceutical Ltd v European Union Intellectual Property Office

Decided
2019-07-03
ECLI
ECLI:EU:C:2019:557
CELEX
62017CJ0668
Finality
Final, the decision cannot be appealed

The court's own keywords

Appeal – EU trade mark – Revocation proceedings – Word mark Boswelan – Genuine use – Absence – Use of the mark in the context of a clinical trial prior to the submission of an application for marketing authorisation for a medicinal product – Proper reason for non-use – Concept.

Interprets

    EUR-LexThe Court

    Read from EU:s publikationsbyrå, Cellar (EUR-Lex och CURIA) on 2026-08-22.

    The row repeats what the source states. It is not a summary, not a conclusion about any single case and not legal advice.

    Verifiable trust signals

    • Six fixed blocks, one source per line
    • No sentence written by a language model
    • Engine version and read date on every answer
    • No customer data, no documents, no advice
    • Model card and audit published under the EU AI Act

    Model cardAudit